The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Obesity Among Children and Adolescents With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Abstract
OBJECTIVES: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most common inherited disorder of adrenal steroid biosynthesis. Patients with the classic form of CAH show androgen excess, with or without salt wasting. There are few studies reporting on higher rates of overweight and obesity among children with CAH. In addition to its role in the regulation of energy balance, leptin is involved in various endocrine and metabolic pathways. In this context, elevated serum leptin levels were reported recently for patients with CAH and were thought to be involved in the development of obesity among these patients. Therefore, the aim of this study was to analyze BMI values, compared with population-based references, for children and adolescents with CAH. Possible contributing factors, such as glucocorticoid therapy, skeletal maturation, birth weight and length, and parental BMI, were correlated with current BMI SD scores (SDS). In addition, the implications of serum leptin levels, corrected for BMI, gender, and Tanner stage, were investigated. METHODS: We performed a cross-sectional retrospective study of 89 children and adolescents with cah (48 female and 41 male subjects; age: 0.2-17.9 years) who presented in our outpatient department during 1 year. All individuals had classic cah, confirmed with molecular genetic analyses, and received substitution therapy (glucocorticoids and mineralocorticoids, if necessary). The quality of therapy was monitored in follow-up visits every 3 to 6 months, on the basis of clinical presentation and laboratory measurement findings according to current guidelines. We grouped the patients into salt wasting and simple virilizing groups, as well as according to current metabolic control. Leptin levels were measured with a commercial radioimmunoassay and calculated as sds. For statistical analyses, standard parametric and nonparametric methods were used. RESULTS: The chronologic ages of the children with CAH were between 0.20 and 17.9 years (mean +/- SD: 8.9 +/- 4.6 years). The BMI SDS of the whole group ranged from -2.7 to 4.3 (mean +/- SD: 0.88 +/- 1.3) and was significantly elevated above 0. Fifteen subjects (16.8%) had BMI SDS of >2.0, which indicated a significantly greater frequency of obesity among patients with CAH than expected for the normal population (expected: 2.27%). There was no significant difference in age and BMI between genders and clinical forms (salt wasting versus simple virilizing). BMI SDS was correlated positively with chronologic age. The BMI SDS did not differ significantly between children receiving hydrocortisone, prednisone, or dexamethasone. Hydrocortisone dosages (including equivalent dosages of prednisone and dexamethasone) ranged from 6.2 to 30.1 mg/m2 body surface area (mean +/- SD: 14.7 +/- 4.8 mg/m2 body surface area). Hydrocortisone dosages were correlated positively with BMI SDS. The relative risk of having a BMI SDS of >2.0 was not significantly elevated among children with prednisone/dexamethasone medication, compared with those with hydrocortisone treatment. In contrast to this, fludrocortisone dosage was not correlated with BMI SDS. Bone age delay, as calculated from the difference of bone age and chronologic age, ranged from -2.9 years to 5.6 years (mean +/- SD: 1.11 +/- 1.8 years) and was significantly elevated; it was correlated positively with BMI SDS. The BMI of parents ranged from 17.8 to 39.0 kg/m2 (median: 24.2 kg/m2). Median BMI values did not differ significantly between fathers and mothers. The relative risk for obesity among our children (BMI SDS of >2.0) was significantly elevated for children with obese parents, compared with those with nonobese parents (relative risk: 4.86). There was no significant correlation of birth length, birth weight, or gestational age with BMI SDS. Serum leptin values ranged from 0.10 to 32 microg/L (median: 4.4 microg/L); they were correlated positively with BMI SDS, chronologic age, and Tanner stage. After transformation into leptin concentration SDS values, the median SDS of 0.42 (range: -5.4 to 3.1) did not differ significantly from 0. CONCLUSIONS: Children and adolescents with CAH have a higher risk of obesity. Glucocorticoid dosage, chronologic age, advanced bone age maturation, and parental obesity contributed to elevated BMI SDS, whereas birth weight and length, serum leptin levels, used glucocorticoid, and fludrocortisone dosage were not associated with obesity. Therefore, children with CAH who become obese should be tightly monitored and should participate concurrently in weight management programs that include obese family members.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately half of pediatric patients are overweight, and 16% to 25% are obese (273-275).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [274]
Citations
Cites
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., Geller, F., Geiß, H. C., Hesse, V., von Hippel, A., Jaeger, U., Johnsen, D., Korte, W., et al. (2001) · Monatsschrift Kinderheilkunde · doi:10.1007/s001120170107 · Cited by 2,175
Body mass index reference curves for the UK, 1990.
Cole, T. J., Freeman, J. V., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.25 · Cited by 2,047
Obesity Evaluation and Treatment: Expert Committee Recommendations
Barlow, S. E., & Dietz, W. H. (1998) · Pediatrics · doi:10.1542/peds.102.3.e29 · Cited by 1,565
NIKLASSON, A., ERICSON, A., FRYER, J. G., KARLBERG, J., LAWRENCE, C., & KARLBERG, P. (1991) · Acta Paediatrica · doi:10.1111/j.1651-2227.1991.tb11945.x · Cited by 739
Blum, W. F. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.2904 · Cited by 690
Early programming of the hypothalamo–pituitary–adrenal axis
MATTHEWS, S. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00690-2 · Cited by 513
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Leptin Inhibition of the Hypothalamic-Pituitary-Adrenal Axis in Response to Stress1
Heiman, M. L., Ahima, R. S., Craft, L. S., Schoner, B., Stephens, T. W., & Flier, J. S. (1997) · Endocrinology · doi:10.1210/endo.138.9.5366 · Cited by 454
EDITORIAL: The developmental origins of adult disease
Barker, D. J. P. (2003) · European Journal of Epidemiology · doi:10.1023/a:1025388901248 · Cited by 406
Research works printed but not linked: 1
- Reinken L, Stolley H, Droese W, van Oost G. Longitudinal data of physical growth of healthy children, II: height, weight, skinfold thickness of children aged 1.5–16 years. Klin Padiatr. 1980;192:25–33
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Studies in pediatric patients showed that approximately half are overweight, and 16–25% are obese (170,171,172).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Out of Bounds? A Critique of the New Policies on Hyperandrogenism in Elite Female Athletes
Karkazis, K., Jordan-Young, R., Davis, G., & Camporesi, S. (2012) · The American Journal of Bioethics · doi:10.1080/15265161.2012.680533 · Cited by 261
“…women with CAH are disproportionately affected by short stature, obesity, dysregulation of mood hormones, and unpredictable, life-threatening salt-losing crises (Charmandari et al. 2004; Eugster et al. 2001; Meyer-Bahlburg 2011; Speiser and White 2003; Stikkelbroeck et al. 2003; Volkl et al. 2006).”
Metadata
- Authors
- Völkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G.
- Affiliations
- Division of Pediatric Endocrinology, Hospital for Children and Adolescents, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-01-01
- Volume
- 117
- Issue
- 1
- Pages
- e98-e105
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2151298139
- Cited by
- 184
- References
- 35
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 11 · 2023: 5 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 7 · 2018: 12 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 12
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, childhood obesity, adolescents, body mass index, leptin, glucocorticoid therapy, salt wasting, masculinization, metabolic control, skeletal maturation, birth weight, parental BMI, hyperandrogenism, metabolic syndrome, insulin resistance, dyslipidemia, hypertriglyceridemia, hyperuricemia
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Age Determination by Skeleton, Child, Child, Preschool, Family Health, Female, Glucocorticoids, Humans, Infant, Male, Obesity, Body Mass Index, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity Among Children and Adolescents With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. https://app.cochat.ai/papers/10.1542/peds.2005-1005
- The paper
- Völkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006). Obesity Among Children and Adolescents With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. PEDIATRICS. https://doi.org/10.1542/peds.2005-1005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.